Larvol Delta - ESK001007-OpenLabel-Extension-Study-to-Evaluate-the-Long-Term-Safety-and-Efficacy-of-ESK001-in-Plaque-Psoriasis

envudeucitinib (ESK-001) - Alumis

http://clinicaltrials.gov/ct2/show/NCT05739435

Jul 29, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next